Rami Daoud

CB & FO, Affinia Therapeutics

Chester Springs, Pennsylvania

About

Male

Rami Daoud is the Chief Business and Financial Officer of Affinia Therapeutics. He previously worked at GeneScience Pharmaceuticals USA as a President. Rami Daoud attended The Wharton School.

Experience

Affinia Therapeutics

CB & FO

View →

Growth49Waltham, Massachusetts, United StatesBiotech/Pharma · Biotechnology

Education

The Wharton School · MBA, Finance & Health Care Management
2000 – 2002
University of Maryland Baltimore · M.S., Physiology (Neurosciene)
1995 – 1996

Headlines from Google News. Social posts load from the platform only when you open a tab.

Affinia Therapeutics closes $40M Series C financing
The Pharma Letter · Oct 7
Doug Williams returns with a ‘FIT’ bet on CAR-Ts; Biogen appoints Mene Pangalos to board
Endpoints News · Sep 13
Affinia Therapeutics appoints Rami Daoud as CB-SFO
The Pharma Letter · Sep 11
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
PR Newswire · Sep 10

People at Affinia Therapeutics

Aaron Tward

Founder

Botond Roska

Co-Founder and Scientific Adviser

Luk Vandenberghe

Scientific Founder & Board Member

Data from: crunchbase